Sirnaomics Ltd.

Informe acción SHSC:2257

Capitalización de mercado: HK$270.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Sirnaomics Dirección

Dirección controles de criterios 1/4

We currently do not have sufficient information about the CEO.

Información clave

Alan Patrick Lu

Chief Executive Officer (CEO)

US$1.1m

Compensación total

Porcentaje del salario del CEO47.4%
Permanencia del CEO3.9yrs
Participación del CEO10.7%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva3.2yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Alan Patrick Lu en comparación con los beneficios de Sirnaomics?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-US$82m

Mar 31 2024n/an/a

-US$80m

Dec 31 2023US$1mUS$515k

-US$79m

Sep 30 2023n/an/a

-US$82m

Jun 30 2023n/an/a

-US$84m

Mar 31 2023n/an/a

-US$86m

Dec 31 2022US$602kUS$520k

-US$88m

Sep 30 2022n/an/a

-US$230m

Jun 30 2022n/an/a

-US$223m

Mar 31 2022n/an/a

-US$218m

Dec 31 2021US$4mUS$379k

-US$213m

Sep 30 2021n/an/a

-US$60m

Dec 31 2020US$370kUS$276k

-US$44m

Dec 31 2019US$379kUS$277k

-US$16m

Compensación vs. Mercado: Alan Patrick's total compensation ($USD1.09M) is above average for companies of similar size in the Hong Kong market ($USD236.76K).

Compensación vs. Ingresos: Alan Patrick's compensation has increased whilst the company is unprofitable.


CEO

Alan Patrick Lu (68 yo)

3.9yrs

Permanencia

US$1,086,000

Compensación

Dr. Yang Lu, also known as Alan Patrick, PhD., is the founder, serves as Chairman of the Board, President & Chief Executive Officer at Sirnaomics Ltd. and has been its Director since October 15, 2020. He w...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Yang Lu
CEO, President & Chairman3.9yrsUS$1.09m10.7%
HK$ 28.9m
Xiaochang Dai
Senior Advisor - Drug Development & Commercialization and Executive Director3.7yrsUS$885.00k2.03%
HK$ 5.5m
Monin Ung
Independent Non Executive Director2.8yrsUS$69.00ksin datos
Cheung-Hoi Yu
Independent Non Executive Director2.8yrsUS$46.00ksin datos
Mo Han Shing
Independent Non-Executive Director2.8yrsUS$69.00ksin datos
Jiankang Zhang
Non Executive Director3.2yrsUS$15.00ksin datos
Mincong Huang
Non Executive Director3.7yrsUS$15.00k1.1%
HK$ 3.0m

3.2yrs

Permanencia media

67yo

Promedio de edad

Junta con experiencia: 2257's board of directors are considered experienced (3.2 years average tenure).